Cargando…

A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study

PURPOSE: This pilot study investigated the in vivo therapeutic potential and tolerability of a multimodal ophthalmic formulation, topical eye drops (TED), for acute mustard gas keratopathy (MGK) using a rabbit model. METHODS: Twenty New Zealand White rabbits were used. Only right eyes of 18 rabbits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathi, Ratnakar, Balne, Praveen K., Sinha, Nishant R., Martin, Lynn M., Kamil, Sabeeh, Landreneau, James R., Gupta, Suneel, Rodier, Jason T., Sinha, Prashant R., Hesemann, Nathan P., Hofmann, Alexandria C., Fink, Michael K., Chaurasia, Shyam S., Mohan, Rajiv R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645241/ https://www.ncbi.nlm.nih.gov/pubmed/33200047 http://dx.doi.org/10.1167/tvst.9.12.6

Ejemplares similares

Mustard Gas Exposure Actuates SMAD2/3 Signaling to Promote Myofibroblast Generation in the Cornea
por: Sinha, Nishant R., et al.
Publicado: (2023)

Six-Month In Vivo Safety Profiling of Topical Ocular AVV5–Decorin Gene Transfer
por: Mohan, Rajiv R., et al.
Publicado: (2021)

Long-Term Safety and Tolerability of BMP7 and HGF Gene Overexpression in Rabbit Cornea
por: Gupta, Suneel, et al.
Publicado: (2021)

Collagen matrix perturbations in corneal stroma of Ossabaw mini pigs with type 2 diabetes
por: Sinha, Nishant R., et al.
Publicado: (2021)

Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo
por: Gupta, Suneel, et al.
Publicado: (2018)

Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo
por: Gupta, Suneel, et al.
Publicado: (2017)

Role of inhibitor of differentiation 3 gene in cellular differentiation of human corneal stromal fibroblasts
por: Gupta, Suneel, et al.
Publicado: (2020)

Evaluation of corneal biomechanical properties in mustard gas keratopathy
por: Naderi, Mostafa, et al.
Publicado: (2019)

Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo
por: Fuchs, Allison A., et al.
Publicado: (2022)

Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms
por: McNutt, Patrick, et al.
Publicado: (2012)

Tear proteomics analysis of patient suffered from delayed mustard gas keratopathy
por: Parvin, Shahram, et al.
Publicado: (2022)

Histopathology Study of Patients with Delayed Mustard Gas Keratopathy 30 Years After Exposure
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2022)

Dr. Dukhan Ram: The pioneer of ophthalmic education in Bihar
por: Sinha, Sony, et al.
Publicado: (2023)

Residents’ proficiency in diagnostics with all ophthalmic equipment – Need of the hour
por: Sinha, Sony, et al.
Publicado: (2021)

Prophylactic ophthalmic bethametazone for sulfur mustard-induced ocular injury
por: Naderi, Mostafa, et al.
Publicado: (2009)

Postpartale Keratopathie
por: Jakob-Girbig, J., et al.
Publicado: (2021)

Role of corneal collagen cross-linking in bullous keratopathy: A systematic review
por: Singh, Mamta, et al.
Publicado: (2023)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

Crystalglobulin-Induced Nephropathy and Keratopathy
por: D’Costa, Matthew R., et al.
Publicado: (2019)

Clinical profile and demographic distribution of band shaped keratopathy in India: A study of 8801 patients
por: Das, Anthony V, et al.
Publicado: (2022)

Management of Candida glabrata infectious crystalline keratopathy with endophthalmitis following penetrating keratoplasty
por: Nagpal, Ritu, et al.
Publicado: (2018)

Safer methods of ophthalmic block
por: Sinha, Renu, et al.
Publicado: (2018)

Pseudophakic bullous keratopathy
por: Pricopie, Stefan, et al.
Publicado: (2017)

Neurotrophic keratopathy: current challenges and future prospects
por: NaPier, Erin, et al.
Publicado: (2022)

Poisoning by "Mustard" Gas
por: Stack, E. H. E., et al.
Publicado: (1920)

Do we need ophthalmic anesthesia as a subspecialty?
por: Sinha, Renu
Publicado: (2023)

Role of 5′TG3′-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition
por: Sharma, Ajay, et al.
Publicado: (2015)

Combined Treatment for Band Keratopathy
por: Najjar, Dany M
Publicado: (2004)

Emergency management: exposure keratopathy
por: Mathenge, Wanjiku
Publicado: (2018)

Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)

Multimodal imaging in paraproteinemic keratopathy
por: Pasricha, Neel D, et al.
Publicado: (2020)

In Vivo Confocal Microscopic Observations of Vortex Keratopathy in Patients with Amiodarone-Induced Keratopathy and Fabry Disease
por: Ikegawa, Yasuhito, et al.
Publicado: (2018)

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use
por: Moshirfar, Majid, et al.
Publicado: (2023)

Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
por: Ranganath, Lakshminarayan R., et al.
Publicado: (2022)

In Vitro Production of Somaclones with Decreased Erucic Acid Content in Indian Mustard [Brassica juncea (Linn.) Czern&Coss]
por: Shyam, Chitralekha, et al.
Publicado: (2021)

Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery
por: Shao, Christine G., et al.
Publicado: (2023)

Huge Bullous Keratopathy following Trauma
por: Panahibazaz, Mahmoudreza, et al.
Publicado: (2010)

Comparison of treatments for bullous keratopathy in rabbits
por: ZHAO, HAIXIA, et al.
Publicado: (2013)

Uveitic band keratopathy: child and adult
por: Nascimento, Heloisa, et al.
Publicado: (2015)

In vivo confocal microscopy of toxic keratopathy
por: Chen, Y, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_867i205mh25b3g0enofldhcs25